Search for Clinical Trial Results

Sponsored By

Plasma Cell Leukemia - 2 Studies Found

Status Study
COMPLETED Study Name: Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
Condition: Plasma Cell Leukemia
Date: 2025-11-04
Interventions: Undergo autologous peripheral blood stem cell transplant
COMPLETED Study Name: Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma
Condition: Plasma Cell Leukemia
Date: 2025-11-04
Interventions: Undergo autologous stem cell transplant